2018 annual financial data
Ovid Therapeutics 2018 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -52,931,683 USD and net income was -51,979,610 USD.
Operating cash flow was -45,558,480 USD.
Get free Ovid Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -52,931,683 USD
- Net income
- -51,979,610 USD
- Operating cash flow
- -45,558,480 USD